TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective […]
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
TransMedics Group (NASDAQ:TMDX – Free Report) had its target price increased by TD Cowen from $100.00 to $130.00 in a report published on Wednesday, Benzinga reports. TD Cowen currently has a buy rating on the stock. Other research analysts also recently issued reports about the stock. Morgan Stanley raised their price objective on shares of […]
TransMedics Group (NASDAQ:TMDX – Free Report) had its price target lifted by Canaccord Genuity Group from $102.00 to $117.00 in a research note published on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently issued reports on the company. Morgan Stanley upped their price objective […]
TransMedics Group (NASDAQ:TMDX – Free Report) had its price target boosted by Canaccord Genuity Group from $102.00 to $117.00 in a research report report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. Other equities analysts also recently issued reports about the company. Morgan Stanley lifted their target price on […]
Piper Sandler reissued their overweight rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a research report released on Wednesday, Benzinga reports. Piper Sandler currently has a $120.00 price target on the stock, up from their previous price target of $95.00. TMDX has been the subject of several other research reports. Morgan Stanley […]
Piper Sandler reiterated their overweight rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a research note released on Wednesday, Benzinga reports. Piper Sandler currently has a $120.00 price objective on the stock, up from their previous price objective of $95.00. A number of other brokerages also recently weighed in on TMDX. JPMorgan […]
TransMedics Group's (TMDX) "Overweight" Rating Reaffirmed at Piper Sandler theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
TransMedics Group, Inc. (NASDAQ:TMDX) Receives $102.00 Consensus PT from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.